Z
Zymeworks
Biotech & Life Sciences · Vancouver, Canada · Founded 2003 · IPO 2017
Global footprint
Where Zymeworks has talent and traffic
team presence
across markets
Talent graph
The shape of Zymeworks's talent
Dealroom maps Zymeworks's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$125M patent portfolio · 84 active families
Where Zymeworks concentrates vs peers
Each axis is a top-10 topic across Zymeworks and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Zymeworks
An AI-synthesized read of the highest-engagement posts about Zymeworks on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zymeworks on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.